Technical Analysis for ANIP - ANI Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 63.44 -0.38% -0.24
ANIP closed down 0.38 percent on Monday, July 1, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
NR7 Range Contraction 0.00%
20 DMA Resistance Bearish -0.38%
50 DMA Resistance Bearish -0.38%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.38%
Pocket Pivot Bullish Swing Setup -0.38%
Volume Surge Other -0.38%
Inside Day Range Contraction -0.38%
Bearish Engulfing Bearish 0.55%
Fell Below 20 DMA Bearish 0.55%

   Recent Intraday Alerts

Alert Time
20 DMA Resistance about 7 hours ago
50 DMA Resistance 3 days ago
Up 2% 3 days ago
Possible Inside Day 3 days ago
20 DMA Resistance 3 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ANI Pharmaceuticals, Inc. Description

ANI Pharmaceuticals, Inc. develops, manufactures, and markets prescription and over-the-counter pharmaceuticals. It offers liquid, powder, oral solid dose, and cough/cold products; and antacids, laxatives, and other stomach remedies. The company also provides hydrocortisone retention enema, esterified estrogen and methyltestosterone, fluvoxamine maleate tablets, hydrocortisone rectal suspension, metoclopramide oral solution, opium tincture, and metoclopramide tablets. In addition, ANI Pharmaceuticals offers contract manufacturing services for other pharmaceutical companies. It offers its products through wholesalers, smaller regional distributors and chains, and pharmacy and retail outlets in the United States. ANI Pharmaceuticals, Inc. was formerly known as ASHCO. The company was founded in 2001 and is based in Baudette, Minnesota. It has manufacturing facilities in Gulfport, Mississippi; and Baudette, Minnesota. ANI Pharmaceuticals, Inc. is a former subsidiary of Bactolac Pharmaceutical Inc.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Acid Retail Outlets Pharmacology Suspension Manufacturing Facilities Contract Manufacturing Chloroarenes Contract Manufacturing Services Cough Estrogen Antiemetics Testosterone Antacid Laxatives Enema Metoclopramide Offers Contract Manufacturing Services Prolactin Releasers

Is ANIP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 70.81
52 Week Low 48.2
Average Volume 162,361
200-Day Moving Average 60.13
50-Day Moving Average 64.35
20-Day Moving Average 63.69
10-Day Moving Average 62.32
Average True Range 2.15
RSI (14) 49.75
ADX 13.35
+DI 24.49
-DI 19.76
Chandelier Exit (Long, 3 ATRs) 62.64
Chandelier Exit (Short, 3 ATRs) 64.88
Upper Bollinger Bands 68.48
Lower Bollinger Band 58.90
Percent B (%b) 0.47
BandWidth 15.04
MACD Line -0.33
MACD Signal Line -0.51
MACD Histogram 0.1842
Fundamentals Value
Market Cap 1.3 Billion
Num Shares 20.4 Million
EPS 0.54
Price-to-Earnings (P/E) Ratio 117.48
Price-to-Sales 2.57
Price-to-Book 2.68
PEG Ratio 1.06
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 65.48
Resistance 3 (R3) 65.49 64.83 65.14
Resistance 2 (R2) 64.83 64.31 64.82 65.03
Resistance 1 (R1) 64.13 63.99 63.80 64.12 64.91
Pivot Point 63.47 63.47 63.30 63.46 63.47
Support 1 (S1) 62.77 62.95 62.44 62.76 61.97
Support 2 (S2) 62.11 62.63 62.10 61.85
Support 3 (S3) 61.41 62.11 61.74
Support 4 (S4) 61.40